Peptide Stack for Anti-Aging: Epithalon, GHK-Cu, and Ipamorelin

The biology of aging is increasingly well understood, and several peptides have emerged from this research with specific evidence for addressing its core mechanisms. Unlike generic anti-aging supplements that work through broad antioxidant pathways, the leading peptides for longevity operate on specific targets: telomere maintenance, cellular repair signaling, and growth hormone optimization.

The combination of epithalon, GHK-Cu, and ipamorelin addresses three distinct but complementary aging mechanisms and represents one of the most evidence-supported anti-aging peptide protocols available in 2026.

The Science Behind Each Compound

Epithalon (also spelled epitalon) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from epithalamin, a polypeptide extract of the pineal gland. It was developed and extensively studied by Russian gerontologist Vladimir Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology over more than four decades of research.

The primary mechanism of epithalon is the activation of telomerase — the enzyme that maintains and elongates telomere length. Telomeres are the protective caps at the ends of chromosomes that shorten with each cell division. Short telomeres are associated with cellular senescence and age-related disease. Research has demonstrated that epithalon activates telomerase in human embryonic cells, increases telomere length in cultures and animal models, and extends lifespan in both invertebrate models and long-term rodent studies. Clinical studies in humans show normalization of circadian rhythms, improved melatonin production, and reductions in cancer incidence over decade-long observation periods.

GHK-Cu (copper peptide GHK-Cu) is a naturally occurring tripeptide (glycyl-histidyl-lysine) complexed with copper ions. Discovered in human plasma by Loren Pickart in the 1970s, GHK-Cu declines significantly with age — from approximately 200 ng/mL at age 20 to under 80 ng/mL by age 60. This decline correlates with reduced wound healing, skin thinning, and impaired tissue repair across multiple organ systems.

GHK-Cu acts as a potent activator of tissue remodeling genes. It upregulates synthesis of collagen, elastin, glycosaminoglycans, and decorin. It activates proteasome activity (cellular cleanup), reduces inflammation via NF-kB downregulation, and stimulates nerve regeneration. In the skin specifically, it increases dermal thickness, reduces fine lines, and improves wound healing. Its antioxidant and anti-inflammatory effects extend systemically — studies suggest it modulates over 4,000 genes, predominantly toward a "healing and regeneration" expression profile.

Ipamorelin in the context of anti-aging addresses one of the most consistent biomarkers of biological aging: declining GH secretion. GH output declines approximately 15% per decade after age 30. This "somatopause" drives many hallmarks of aging: reduced lean mass, increased visceral fat, impaired sleep, reduced bone density, and slower tissue repair. Ipamorelin safely stimulates natural GH release in a pulsatile pattern that closely mimics youthful GH secretion, without the side effects of exogenous GH administration.

Anti-Aging Protocol

Epithalon

• Dose: 100 mcg per injection, OR 5–10 mg total per cycle
• Route: Subcutaneous injection
• Frequency: Daily injections OR as a concentrated course (10 mg over 10–20 days)
• Cycling: 1–2 cycles per year (spring and fall are commonly used)
• Note: Epithalon has a very long-acting effect; frequent year-round use is not typical or necessary

GHK-Cu

• Dose: 1–2 mg per injection (systemic/subcutaneous)
• Route: Subcutaneous injection OR topical (for skin-specific effects)
• Frequency: Daily injections, 5 days on, 2 days off
• Cycle: 8–12 weeks on, 4 weeks off
• Topical: 1–3% GHK-Cu concentration in serum or cream applied to face and neck twice daily

Ipamorelin

• Dose: 200–300 mcg per injection
• Route: Subcutaneous injection
• Timing: Before bed, fasted (2+ hours post-meal)
• Frequency: Daily, 5 days on, 2 days off
• Cycle: 12–16 weeks on, 4–6 weeks off

Cycling Protocol for Long-Term Use

For an anti-aging protocol designed for long-term sustainability, a quarterly cycling structure works well:

Months 1–3 (On Cycle)

• Daily ipamorelin before bed
• Daily GHK-Cu injection (5 on, 2 off)
• Epithalon course in week 1 (10 daily injections of 100 mcg each) then pause

Month 4 (Off Cycle)

• All injections paused
• Continue topical GHK-Cu application if desired (topical use does not require cycling)
• Assess results, measure IGF-1 if not done mid-cycle

Repeat quarterly. This structure provides meaningful on-cycle benefit while preserving receptor sensitivity and allowing the body to consolidate improvements during off periods.

Expected Benefits and Timeline

Anti-aging interventions work slowly by definition. Unlike performance-enhancing peptide stacks where effects are felt within weeks, longevity protocols produce their most significant benefits over 6–24 months of consistent use.

Months 1–2: Improved sleep quality and deeper sleep architecture from ipamorelin. Subtle skin improvements from GHK-Cu (improved texture, reduced redness). Some users report improved mood and reduced anxiety, consistent with GHK-Cu's known neurological effects.

Months 3–6: Measurable skin changes become visible — reduced fine lines, improved skin elasticity, and a more even tone. Lean mass improvements from enhanced GH output. Faster recovery from physical exertion and minor injuries.

6–24 months: Long-term users of epithalon in clinical settings report normalized cortisol rhythms, improved melatonin output, and reduced oxidative stress biomarkers. While telomere extension cannot be easily measured in a clinical setting, the downstream effects of telomerase activation manifest as slower biological aging progression on standard aging biomarkers.

For those tracking longevity markers, consider measuring: IGF-1, hsCRP (inflammation), telomere length (available through specialty labs), GlycanAge or epigenetic age tests, skin elasticity, and body composition. See our longevity supplements evidence guide for context on interpreting these markers.

Synergies With Lifestyle Interventions

This peptide stack amplifies the effects of foundational longevity practices rather than replacing them:

Sleep: Ipamorelin's benefits are most pronounced with high sleep quality. Optimize sleep hygiene, maintain a consistent sleep schedule, and minimize blue light exposure before bed.

Exercise: Resistance training and high-intensity interval training both stimulate GH release and synergize powerfully with ipamorelin. GHK-Cu's collagen-stimulating effects reduce injury risk and accelerate recovery, making consistent training more sustainable.

Nutrition: Caloric restriction and time-restricted eating activate many of the same longevity pathways as epithalon (mTOR inhibition, autophagy). A diet rich in antioxidants and low in processed foods reduces the inflammatory burden that GHK-Cu works against.

Consider pairing this stack with evidence-based longevity supplements such as NMN (for NAD+ support), resveratrol, and spermidine. For an in-depth comparison of peptide approaches with traditional longevity supplements, see our longevity peptide protocol guide.

Frequently Asked Questions

Q: Is epithalon safe for long-term use? The clinical research on epithalon — much of it from Russian institutions but also peer-reviewed — spans over 40 years with thousands of subjects and does not indicate significant safety concerns. The peptide is derived from a naturally occurring pineal peptide and appears to normalize rather than overstimulate biological systems. That said, human long-term data from Western randomized controlled trials is limited, and conservative cycling (1–2 courses per year) is the standard precautionary approach.

Q: Can I use GHK-Cu topically instead of injecting it? Yes. Topical GHK-Cu at concentrations of 1–3% has strong evidence for skin-specific anti-aging effects — it penetrates the dermis effectively and stimulates local collagen synthesis. For systemic benefits (nerve regeneration, organ-level remodeling, anti-inflammatory effects), subcutaneous injection is required. Many users combine topical GHK-Cu for skin with occasional injections for systemic effects.

Q: How does this stack compare to just using exogenous HGH? Exogenous HGH (recombinous human growth hormone) produces stronger and faster body composition effects but carries significant risks: IGF-1 elevation at pharmacological levels, insulin resistance, acromegaly risk with long-term use, and complete suppression of natural GH production. Ipamorelin stimulates your own pituitary within physiological limits, maintaining natural feedback mechanisms and a much cleaner safety profile. For anti-aging purposes (rather than competitive bodybuilding), the ipamorelin approach is preferred by most longevity-focused practitioners.

Q: At what age should someone start an anti-aging peptide stack? Most research and clinical practice suggests that anti-aging peptide protocols are most relevant starting in the mid-30s to early 40s, when GH decline becomes measurable and telomere shortening begins to affect cellular function meaningfully. Using these peptides in your 20s is not well-supported and may interfere with still-active natural physiological processes. Baseline bloodwork including IGF-1 and hormonal panel is recommended before starting at any age.

Q: Can women use this anti-aging stack? Yes. Women may actually benefit more from GHK-Cu's skin-related effects given thinner and more rapidly aging skin post-menopause. Epithalon's hormonal normalizing effects have been studied in women specifically, showing improvements in menopausal symptoms and cancer risk reduction in clinical research. For a comprehensive women's guide, see our women's peptide stack guide.